Use access key #2 to skip to page content.
$52.78 1.00 (1.93%)
5/12/2008 4:00 PM

Abbott Laboratories (ABT)

CAPS Rating:
****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ABT

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

666 Outperforms
55 Underperforms
 

All-Stars

161 Outperforms
11 Underperforms
 

Wall Street

22 Outperforms
0 Underperforms
 

Players bullish on ABT are also bullish on:

Players bearish on ABT are also bearish on:

Ticker Tags

Medical Device (42), S&P 500 (484), Chicago (23), Big Pharma (12), Illinois (19), Drug Manufacturers - Major (27), Multinational Company (16), Dividend (184), Mega Cap (146)
Suggest a tag

Abbott Laboratories At A Glance

Current Price: $52.78
Last Trade Time: 5/12/2008 4:00 PM
Open: $0.00
Previous Close: $51.78
Daily Range: $51.97 - $52.89
52-Week Range: $49.58 - $61.09
Volume: 8,046,022
Market Cap: $79.91B
P/E Ratio: 20.71
Compare Our Special Broker Offers!

Stock Trends

ABT VS S&P 500 (SPY)

ABT 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

3

Abbott Laboratories (ABT)

Avatar pazyarte (79.30) Submitted: 11/10/07 12:33 PM

ABT due to be purchased this week. I am bullish on pharmaceuticals and medical equipment stocks. It is what will be greatly needed by Boomers and continues to develop great products both as generics and new over-the counter products. Great future.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Abbott Laboratories (ABT)

Avatar boiseidfool (76.60) Submitted: 3/03/07 9:35 AM

Idaho has filed a lawsuit that alleges Abbott Laboratories falsified wholesale drug prices and that the state has overpaid Medicaid reimbursements because of the manipulated drug prices. In the complaint, the Idaho attorney general's office says the prices charged to hospitals and pharmacies for Ab...More

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 103 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ABT)

Avatar brokerGObroke (33.61) Submitted: 5/08/08 1:01 PM : Outperform Start Price: $51.35 ABT Score: 2.18

going up now....hopefully


Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar deuspecuniae (< 20) Submitted: 5/01/08 12:11 PM : Outperform Start Price: $53.64 ABT Score: -2.22

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar Alzo10 (96.50) Submitted: 4/29/08 3:34 PM : Outperform Start Price: $53.53 ABT Score: -2.25

Abbot continues to outperform their peers on a revenue and product basis. It's only a matter of time before the stock begins to reflect it.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar woodruffdavid (67.48) Submitted: 4/28/08 11:37 PM : Outperform Start Price: $53.32 ABT Score: -1.82

This stock is included in the Morningstar "Dividend Portfolio," which I use as my core stock group. I highly suggest anyone interested in dividend income take a look at this grouping of quality income producing stocks.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar oinochoe (60.56) Submitted: 4/25/08 9:52 PM : Outperform Start Price: $51.72 ABT Score: 1.59

Again, I'm not interested in short term gains, so I'd buy Abbott (50.78) if I had some extra cash to throw at it. If the price stays this low later in 2008 I will buy and hold for a few years.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 103 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 22 of 22  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackUBS 93.95 05/09/08 Outperform NS $51.23+3.03%+1.49%+1.54
TrackWachovia 78.50 03/20/08 Outperform NS $54.32-2.83%+8.00%-10.83
TrackStanfordRes < 20 10/09/07 Outperform NS $54.03-2.31%-9.73%+7.42
TrackRichAster 79.06 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 83.04 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackBillNygren 54.22 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 81.11 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 93.10 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley 94.97 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackEdwardOwens 71.22 09/30/07 Outperform NS $52.65+0.24%-7.94%+8.18 Toggle the visibility of 60-Second Pitch and replies
TrackScottBleier < 20 07/20/07 Outperform 3M $51.92+1.66%-8.50%+10.16
TrackZacks 93.49 05/29/07 Outperform 3M $55.29-4.54%-7.74%+3.20 Toggle the visibility of 60-Second Pitch and replies
TrackLehmanBros 86.05 05/07/07 Outperform NS $57.52-8.25%-6.95%-1.30
TrackGaryBSmith 35.02 03/31/07 Outperform 3W $54.46-3.09%-1.08%-2.00
TrackMichaelSivy 53.58 03/20/07 Outperform 1Y $54.35-2.89%-0.36%-2.53
TrackMatrix 89.66 03/01/07 Outperform NS $52.16+1.19%+0.80%+0.38
TrackRBCCapMkts 90.06 01/25/07 Outperform NS $51.34+2.81%-2.25%+5.07
TrackAGEdwards 88.62 01/22/07 Outperform NS $51.63+2.23%-1.82%+4.06
TrackPrudential 84.40 01/19/07 Outperform NS $51.90+1.70%-1.56%+3.26
TrackJimCramer 81.00 12/06/06 Outperform 3W $46.59+13.29%-0.89%+14.17
TrackMorganStan 97.59 11/15/06 Outperform NS $45.22+16.71%+0.65%+16.06
TrackBofASec 94.03 09/05/06 Outperform NS $47.13+11.98%+6.81%+5.17
TrackRochdale < 20 08/16/06 Outperform NS $47.55+11.00%+9.79%+1.21

Results 1 - 22 of 22  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.